Focus

Bluebird

LATEST

Health News
Health News

FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder

FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder
|
Companies
Companies

Bluebird’s $2.8 Million Gene Therapy Becomes Most Expensive Drug After US Approval

Bluebird’s $2.8 Million Gene Therapy Becomes Most Expensive Drug After US Approval
|
Inspired
Inspired

Beautiful Mountain Bluebirds Are the BLUEST of All Bluebirds–and They’re on the Rise

Beautiful Mountain Bluebirds Are the BLUEST of All Bluebirds–and They’re on the Rise
|
The Epoch Times

American Express and Wal-Mart’s Bluebird Venture

American Express and Wal-Mart’s Bluebird Venture
|
Health News
Health News

FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder

FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder
|
Companies
Companies

Bluebird’s $2.8 Million Gene Therapy Becomes Most Expensive Drug After US Approval

Bluebird’s $2.8 Million Gene Therapy Becomes Most Expensive Drug After US Approval
|
Inspired
Inspired

Beautiful Mountain Bluebirds Are the BLUEST of All Bluebirds–and They’re on the Rise

Beautiful Mountain Bluebirds Are the BLUEST of All Bluebirds–and They’re on the Rise
|
The Epoch Times

American Express and Wal-Mart’s Bluebird Venture

American Express and Wal-Mart’s Bluebird Venture
|